Compare Cassava Sciences Inc (FLNA) vs KB Financial Group, Inc. (KB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs KB Financial Group, Inc. — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while KB Financial Group, Inc. trades at $117.53 (market cap $41.21B). The key difference: KB Financial Group, Inc. is far larger — about 863× Cassava Sciences Inc's market cap, and KB Financial Group, Inc. pays a 2.67% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | KB | |
|---|---|---|
Market Cap | $47.75M | $41.21B |
Sector | Health | Financials |
52-Week High | $4.64 | $124.01 |
52-Week Low | $0.87 | $77.50 |
Enterprise Value | -$34.93M | — |
Dividend Yield | — | 2.67% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About KB Financial Group, Inc.
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →
